Epigenetic reader domain inhibitor CeMMEC13, Purity ≥98%

Synonym: 1790895-25-8; CeMMEC13; 1-Methyl-2-oxo-1,2-dihydro-quinoline-4-carboxylic acid (2,3-dihydro-benzo[1,4]dioxin-6-yl)-amide; N-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1-methyl-2-oxo-1,2-dihydroquinoline-4-carboxamide; CHEMBL4871450; Epigenetic reader domain inhibitor

CAS Number: 1790895-25-8
Compound CID: 110694558

Product Size

5 mg; 10 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

CeMMEC13, soluble in DMSO and ethanol and insoluble in water, disrupts the function of proteins that recognize and bind specific epigenetic marks, affecting the interpretation of epigenetic signals.

Molecular Weight

336.34

Molecular Formula

C₁₉H₁₆N₂O₄

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 62 mg/mL (184.33 mM); Water: Insoluble; Ethanol: 6 mg/mL (17.83 mM)

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

CeMMEC13 can be used to investigate the inhibition of the bromodomain-containing protein 4 (BRD4) in cancer and inflammation.

Storage

Store at -20ºC.